JAG1 and ductal breast carcinoma in situ: Overexpression of NOTCH receptors has been implicated in ductal carcinoma in situ (DCIS) and invasive breast cancer [12,13], and high levels of the NOTCH ligand JAG1 appear to predict a poor overall survival [14].